New study reveals why Alzheimer’s disease may worsen faster in women.

Alzheimer’s disease: New Mayo Clinic study reveals faster progression in women

Alzheimer’s disease progression is significantly accelerated in women when Parkinson’s-related proteins are present, according to new Mayo Clinic research. This finding reshapes current scientific understanding of how neurodegenerative diseases interact and why women are disproportionately affected.

The study identifies a critical biological interaction between tau and alpha-synuclein proteins, demonstrating that coexisting pathologies can dramatically alter disease trajectory. It also highlights the importance of sex-specific research in neurology, challenging long-standing assumptions that Alzheimer’s progresses uniformly across populations.

This article explains the study in detail, clarifies the underlying science, and outlines practical dietary strategies that may reduce the risk of Alzheimer’s disease and Parkinson’s disease. The analysis integrates clinical, biological and epidemiological perspectives to provide a comprehensive and actionable understanding.

Key Takeaways

Women with both tau and alpha-synuclein abnormalities show dramatically faster disease progression.
Protein interactions in the brain can accelerate neurodegeneration beyond single-disease models.
Sex-specific biology must guide future Alzheimer’s research and treatment strategies.
Dietary patterns significantly influence long-term neurological health and disease risk.

Understanding Alzheimer’s disease in a modern scientific context

Alzheimer’s disease is a progressive neurodegenerative disorder characterised by cognitive decline, memory impairment and eventual loss of independent function.

At the biological level, the disease is defined by the accumulation of abnormal proteins in the brain, primarily tau tangles and amyloid-beta plaques. These protein aggregates disrupt neuronal communication, impair synaptic function and ultimately lead to neuronal death.

Historically, Alzheimer’s research has focused on amyloid-beta as the primary driver of pathology. More recent work has shifted attention toward tau protein, which correlates more closely with disease severity and progression.

Tau stabilises microtubules in healthy neurons, but in Alzheimer’s disease it becomes hyperphosphorylated, misfolds and aggregates into neurofibrillary tangles.

The new Mayo Clinic published in JAMA Network Open expands this framework by examining how Alzheimer’s pathology interacts with other neurodegenerative processes, particularly those associated with Parkinson’s disease.

This represents a significant shift from viewing neurodegenerative diseases as isolated conditions to understanding them as overlapping and interacting pathologies.

The Mayo Clinic study: design and findings

The study reports that “Alzheimer’s-related brain changes progressed up to 20 times faster in women who also had abnormal levels of a Parkinson’s-related protein”.

This striking finding emerged from a large-scale analysis involving 415 participants enrolled in the Alzheimer’s Disease Neuroimaging Initiative, a longitudinal research consortium designed to track brain changes over time.

That interaction could help explain a long-standing disparity: women make up nearly two-thirds of people living with Alzheimer’s disease in the US.

Participants underwent cerebrospinal fluid testing to identify abnormal levels of alpha-synuclein, a protein strongly associated with Parkinson’s disease and related disorders such as dementia with Lewy bodies.

In addition, repeated brain imaging was used to measure tau accumulation, allowing researchers to quantify disease progression with high precision.

Approximately 17 percent of participants exhibited abnormal alpha-synuclein levels. Among those with both Alzheimer’s pathology and alpha-synuclein abnormalities, women demonstrated dramatically accelerated tau accumulation compared to men with similar biological profiles.

This sex-specific effect was the central finding of the study. It suggests that the interaction between these two proteins creates a compounding pathological effect that disproportionately affects women.

The role of alpha-synuclein in neurodegeneration

Alpha-synuclein is a protein that plays a role in synaptic function under normal physiological conditions. In pathological states, however, it misfolds and aggregates into structures known as Lewy bodies. These aggregates are a hallmark of Parkinson’s disease and dementia with Lewy bodies.

The study explains that “tau and α-synuclein occur naturally in the brain. In neurodegenerative diseases, however, these proteins can misfold and clump together, forming abnormal deposits”. This process disrupts neuronal signalling and accelerates cognitive decline.

What makes the Mayo Clinic study particularly important is its focus on co-pathology. Many individuals with Alzheimer’s disease also exhibit alpha-synuclein accumulation, yet the implications of this overlap have not been fully understood until now.

The findings indicate that alpha-synuclein is not merely a secondary feature but may actively drive faster disease progression, at least in certain populations.

Why women are disproportionately affected

Women account for nearly two-thirds of Alzheimer’s cases in the United States, a disparity that has often been attributed to longer life expectancy. The Mayo Clinic study challenges this explanation by identifying a biological mechanism that may contribute to increased vulnerability.

Dr Kejal Kantarci, senior author of the study, emphasised the importance of recognising these differences: “Recognising these sex-specific differences could help us design more targeted clinical trials and ultimately more personalised treatment strategies.”

The study suggests that hormonal, genetic or metabolic factors may influence how tau and alpha-synuclein interact in the female brain. These differences could alter protein folding, aggregation or clearance mechanisms, leading to more aggressive disease progression.

Dr Elijah Mak, the study’s first author, highlighted the broader implications: “This opens an entirely new direction for understanding why women bear a disproportionate burden of dementia.”

Polycystic ovary syndrome (PCOS) treatment and medication online

One in ten women in the U.S. struggle with polycystic ovary syndrome (PCOS).1 Speak with a top-rated physician online for a personalized consultation today, and get the right PCOS medication and treatment plan for your symptoms.*

Implications for diagnosis and treatment

The discovery of sex-specific differences in disease progression has significant implications for clinical practice. Current diagnostic criteria and treatment approaches largely assume uniform disease behaviour across populations. This assumption may lead to underdiagnosis or suboptimal treatment in certain groups.

The findings suggest that clinicians should consider coexisting pathologies when assessing patients with Alzheimer’s disease. Biomarker testing for alpha-synuclein may become increasingly important in identifying individuals at higher risk of rapid progression.

From a therapeutic perspective, the study supports the development of targeted treatments that address multiple pathological processes simultaneously. Rather than focusing solely on amyloid or tau, future therapies may need to address the interaction between different protein systems.

The researchers are now investigating whether similar sex-specific effects occur in dementia with Lewy bodies, where alpha-synuclein is the primary pathology. This work will help determine whether the observed phenomenon is unique to Alzheimer’s disease or part of a broader pattern across neurodegenerative disorders.

The broader scientific significance

The Mayo Clinic study represents a shift toward a more integrated understanding of neurodegeneration. It highlights the importance of studying disease interactions rather than isolated mechanisms.

This approach aligns with emerging frameworks in neuroscience that emphasise network dysfunction, protein interactions and systemic factors. It also reinforces the need for precision medicine, where treatments are tailored to individual biological profiles.

The study’s use of advanced imaging and biomarker analysis demonstrates the value of longitudinal data in understanding disease progression. By tracking changes over time, researchers can identify patterns that are not visible in cross-sectional studies.

Diabetes treatment available online today

In order to treat your diabetes, consult with one of our board-certified doctors online today to prescribe the right treatment plan to manage your blood sugar levels. Get a new diabetes prescription to treat diabetes or refill an existing prescription today.*

Dietary strategies to reduce Alzheimer’s and Parkinson’s risk

While genetic and biological factors play a significant role in Alzheimer’s disease, lifestyle choices also influence risk. Diet, in particular, has been extensively studied for its impact on brain health.

A growing body of evidence supports the role of dietary patterns in reducing the risk of neurodegenerative diseases. These patterns focus on nutrient-dense foods that support neuronal function, reduce inflammation and promote vascular health.

The Mediterranean and MIND diets

The Mediterranean diet is one of the most widely studied dietary patterns for brain health. It emphasises fruits, vegetables, whole grains, legumes, nuts, olive oil and moderate consumption of fish.

The MIND diet, a hybrid of the Mediterranean and DASH diets, is specifically designed to reduce cognitive decline. It prioritises leafy green vegetables, berries, nuts, whole grains, fish and poultry while limiting red meat, butter, cheese and processed foods.

Research has shown that adherence to the MIND diet is associated with a significantly lower risk of Alzheimer’s disease. Even moderate adherence can produce measurable benefits.

Never read another label again

We select ingredients and meals to match your dietary preferences.

Key nutrients for neurological protection

Certain nutrients play a critical role in maintaining brain health and reducing disease risk. Omega-3 fatty acids, found in fatty fish such as salmon and sardines, support neuronal membrane integrity and reduce inflammation.

Antioxidants, including vitamins C and E, protect against oxidative stress, which is a major contributor to neurodegeneration. Polyphenols, found in berries, tea and dark chocolate, also provide neuroprotective effects.

B vitamins, particularly B6, B12 and folate, are essential for homocysteine metabolism. Elevated homocysteine levels are associated with increased risk of cognitive decline.

Reducing harmful dietary factors

In addition to increasing protective nutrients, reducing harmful dietary components is equally important. Diets high in saturated fats, refined sugars and processed foods are associated with increased inflammation and oxidative stress.

Excessive sugar intake can impair insulin signalling in the brain, contributing to what some researchers describe as “type 3 diabetes”. This condition is linked to Alzheimer’s disease.

Trans fats and highly processed oils should also be avoided, as they can damage vascular health and contribute to plaque formation.

The easiest way to eat healthy.

Good-for-you groceries, simple recipes, recommended just for you. Take the quiz today.

The role of gut health

Emerging research highlights the connection between gut health and brain function, often referred to as the gut-brain axis. A healthy gut microbiome supports immune function, reduces inflammation and influences neurotransmitter production.

Dietary fibre, found in fruits, vegetables and whole grains, promotes a healthy microbiome. Fermented foods such as yoghurt, kefir and sauerkraut provide beneficial probiotics.

Maintaining gut health may play a role in reducing the risk of both Alzheimer’s disease and Parkinson’s disease, particularly given the involvement of alpha-synuclein in the gut in early Parkinson’s pathology.

Practical dietary recommendations

A practical approach to reducing neurodegenerative risk involves consistent dietary habits rather than short-term interventions. Daily consumption of leafy greens, berries and whole grains provides a foundation for brain health.

Replacing saturated fats with healthier alternatives such as olive oil improves cardiovascular function, which is closely linked to cognitive health. Regular consumption of fish provides essential omega-3 fatty acids.

Limiting processed foods, sugary beverages and excessive alcohol intake reduces inflammatory burden and supports long-term neurological resilience.

Hydration is also important, as even mild dehydration can impair cognitive function.

The easiest way to eat healthy.

Good-for-you groceries, simple recipes, recommended just for you.

A grocery trip in one click.

Fresh produce, premium proteins—we’ve got everything to keep your fridge full and taste buds happy.

Learn more

Integrating diet with broader lifestyle factors

Diet is one component of a broader lifestyle strategy for reducing Alzheimer’s disease risk. Physical activity, cognitive engagement, sleep quality and stress management all contribute to brain health.

Regular exercise improves blood flow to the brain, supports neurogenesis and reduces inflammation. Cognitive activities such as reading, learning new skills and social interaction help maintain neural networks.

Sleep is critical for clearing metabolic waste from the brain, including beta-amyloid. Chronic sleep deprivation is associated with increased risk of Alzheimer’s disease.

Conclusion

The Mayo Clinic study provides compelling evidence that Alzheimer’s disease progression is influenced by interactions between multiple pathological proteins and that these interactions can differ significantly between men and women. The finding that alpha-synuclein accelerates tau accumulation in women offers a new perspective on why women are disproportionately affected by the disease.

This research underscores the need for personalised approaches to diagnosis and treatment, as well as continued investigation into the complex mechanisms underlying neurodegeneration. At the same time, it reinforces the importance of modifiable lifestyle factors, particularly diet, in reducing disease risk.

By combining advances in biomedical research with practical preventive strategies, it is possible to move toward a more comprehensive and effective approach to addressing Alzheimer’s disease on a global scale.